全球合成小分子 API 市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測

全球合成小分子 API 市場需求預計將從 2022 年的 1358.8 億美元達到 2030 年近 272.99 億美元的市場規模，2023-2030 年研究期間年複合成長率為 8.06%。

合成小分子API是低分子量的活性藥物成分。合成小分子 API 是用於生物過程和藥物開發的有機成分。此外，任何藥物成品都可以單獨或組合使用API​​。它是製藥行業必不可少的關鍵成分。該分子被證明在疾病的診斷、預防和治療方面非常有效。合成小分子API的分子量為900道爾頓。

市場動態：

小分子 API 市場受到製藥行業技術進步導致合成小分子 API 產量增加以及對學名藥需求不斷成長的影響。多個治療領域對慢性疾病有效治療的需求推動了對合成小分子 API 的需求。人口老齡化的加劇、疾病和治療意識的增強、研發活動的激增、醫療保健基礎設施的改善以及醫療保健支出的增加是促進合成小分子原料藥市場成長的幾個因素。用於低成本藥品生產的 API 等原料的需求進一步加速了成長。外包趨勢的增加和藥物小規模生產的激增將進一步促進合成小分子 API 的市場成長。

該研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球合成小分子原料藥市場的各個細分市場進行了包容性評估。合成小分子原料藥行業的成長和趨勢為本研究提供了整體方法。

區域分析：

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲合成小分子 API 市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。合成小分子 API 市場的主要參與者包括 Bristol-Myers Squibb Company、Cipla Inc.、Boehringer Ingelheim International GmbH、Merck & Co. Inc.、AbbVie Inc.、Aurobindo Pharma、Sun Pharmaceutical Industries Ltd.、Teva Pharmaceutical Industries Ltd. .、Albemarle Corporation、Viatris Inc.、Dr. Reddy's Laboratories Ltd.。本部分包含競爭格局的整體視圖，其中包括各種戰略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他開發。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第一章：前言

• 報告說明
  • 客觀的
  • 目標受眾
  • 獨特的銷售主張 (USP) 和產品
• 研究範圍
• 研究方法論
  • 市場研究過程
  • 市場研究方法論

第 2 章：執行摘要

• 市場亮點
• 全球市場概況

第 3 章：合成小分子原料藥 - 行業分析

• 簡介 - 市場動態
• 市場促進因素
• 市場限制
• 機會
• 行業動態
• 波特五力分析
• 市場吸引力分析
  • 製造商的市場吸引力分析
  • 市場吸引力分析：按應用分類
  • 市場吸引力分析：按地區

第 4 章：價值鏈分析

• 價值鏈分析
• 原料分析
  • 原料清單
  • 原料廠商清單
  • 主要原料價格走勢
• 潛在買家名單
• 行銷管道
  • 直效行銷
  • 間接行銷
  • 行銷管道發展趨勢

第 5 章：COVID-19 爆發的影響分析

第 6 章：全球合成小分子 API 市場分析：按製造商分類

• 製造商概覽
• 歷史和預測數據
• 按製造商分析
• 內部
• 外包

第 7 章：全球合成小分子 API 市場分析：按應用分類

• 概述：按應用
• 歷史和預測數據
• 分析：按應用
• 心臟病學
• 腫瘤學
• 中樞神經系統和神經病學
• 骨科
• 內分泌科
• 肺科
• 胃腸病學
• 腎臟病學
• 眼科
• 其他

第 8 章：全球合成小分子 API 市場分析：按地理位置

• 區域展望
• 介紹
• 北美銷售分析
  • 概述、歷史和預測銷售分析
  • 北美按細分市場銷售分析
  • 北美按國家/地區銷售分析
  • 美國銷售分析
  • 加拿大銷售分析
  • 墨西哥銷售分析
• 歐洲銷售分析
  • 概述、歷史和預測銷售分析
  • 歐洲按細分市場銷售分析
  • 歐洲按國家/地區銷售分析
  • 英國銷售分析
  • 法國銷售分析
  • 德國銷售分析
  • 義大利銷售分析
  • 俄羅斯銷售分析
  • 歐洲其他地區銷售分析
• 亞太地區銷售分析
  • 概述、歷史和預測銷售分析
  • 亞太地區按細分市場銷售分析
  • 亞太地區國家/地區銷售分析
  • 中國銷售分析
  • 印度銷售分析
  • 日本銷售分析
  • 韓國銷售分析
  • 澳大利亞銷售分析
  • 亞太地區其他地區銷售分析
• 拉丁美洲銷售分析
  • 概述、歷史和預測銷售分析
  • 拉丁美洲按細分市場銷售分析
  • 拉丁美洲按國家/地區銷售分析
  • 巴西銷售分析
  • 阿根廷銷售分析
  • 秘魯銷售分析
  • 智利銷售分析
  • 拉丁美洲其他地區銷售分析
• 中東和非洲銷售分析
  • 概述、歷史和預測銷售分析
  • 中東和非洲按細分市場銷售分析
  • 中東和非洲國家銷售分析
  • 沙烏地阿拉伯銷售分析
  • 阿拉伯聯合大公國銷售分析
  • 以色列銷售分析
  • 南非銷售分析
  • 中東其他地區和非洲銷售分析

第 9 章：合成小分子原料藥公司的競爭格局

• 合成小分子原料藥市場競爭
• 夥伴關係/協作/協議
• 併購
• 新產品發布
• 其他發展

第 10 章：公司簡介

• 頂級公司市場佔有率分析
• 市場集中度
• Bristol-Myers Squibb Company
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Cipla Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Boehringer Ingelheim International GmbH
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Merck & Co. Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• AbbVie Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Aurobindo Pharma
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Sun Pharmaceutical Industries Ltd.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Teva Pharmaceutical Industries Ltd.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Albemarle Corporation
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Viatris Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Dr. Reddy's Laboratories Ltd.
• 公司簡介
• 公司收入
• 產品
• 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私營公司，則可能不包括在內

The global demand for Synthetic Small Molecule API Market is presumed to reach the market size of nearly USD 272.99 BN by 2030 from USD 135.88 BN in 2022 with a CAGR of 8.06% under the study period 2023 - 2030.

Synthetic small molecules API are active pharmaceutical ingredients with low molecular weight. The synthetic small molecule API is an organic component used in biological procedures and drug development. Furthermore, any finished pharmaceutical product can utilize API alone or in combination. It is an essential key ingredient in the pharmaceutical sector. The molecule is proven highly effective in the diagnosis, prevention & treatment of the disease. The molecular weight of synthetic small molecule API is 900 Daltons.

MARKET DYNAMICS:

The market for small molecule APIs is influenced by both the increased production of synthetic small molecule APIs as a result of technological advancement in the pharmaceutical industry and the rising need for generic drugs. The demand for synthetic small molecule API has been driven by the need for effective treatments for chronic diseases in several therapeutic fields. The growing ageing population & increase in disease & treatment awareness, the surge in R&D activities, improved healthcare infrastructure, and rising healthcare expenditure are several factors that are contributing to the market growth of synthetic small molecule API. Growth is further accelerated by the demand for raw materials like API for the low-cost manufacturing of drugs & pharmaceuticals. Increasing outsourcing trends and a surge in small-scale production of drugs will further augment the market growth of synthetic small molecule APIs.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of synthetic small molecule api. The growth and trends of synthetic small molecule api industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the synthetic small molecule api market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Manufacturer

• In-House
• Outsourced

By Application

• Cardiology
• Oncology
• CNS And Neurology
• Orthopedic
• Endocrinology
• Pulmonology
• Gastroenterology
• Nephrology
• Ophthalmology
• Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Synthetic Small Molecule API market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the synthetic small molecule api market include Bristol-Myers Squibb Company, Cipla Inc., Boehringer Ingelheim International GmbH, Merck & Co. Inc., AbbVie Inc., Aurobindo Pharma, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Albemarle Corporation, Viatris Inc., Dr. Reddy's Laboratories Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . SYNTHETIC SMALL MOLECULE API - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Manufacturer
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL SYNTHETIC SMALL MOLECULE API MARKET ANALYSIS BY MANUFACTURER

• 6.1 Overview by Manufacturer
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Manufacturer
• 6.4 In-house Historic and Forecast Sales by Regions
• 6.5 Outsourced Historic and Forecast Sales by Regions

7 . GLOBAL SYNTHETIC SMALL MOLECULE API MARKET ANALYSIS BY APPLICATION

• 7.1 Overview by Application
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Application
• 7.4 Cardiology Historic and Forecast Sales by Regions
• 7.5 Oncology Historic and Forecast Sales by Regions
• 7.6 CNS And Neurology Historic and Forecast Sales by Regions
• 7.7 Orthopedic Historic and Forecast Sales by Regions
• 7.8 Endocrinology Historic and Forecast Sales by Regions
• 7.9 Pulmonology Historic and Forecast Sales by Regions
• 7.10. Gastroenterology Historic and Forecast Sales by Regions
• 7.11 Nephrology Historic and Forecast Sales by Regions
• 7.12 Ophthalmology Historic and Forecast Sales by Regions
• 7.13 Others Historic and Forecast Sales by Regions

8 . GLOBAL SYNTHETIC SMALL MOLECULE API MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1. Overview, Historic and Forecast Sales Analysis
  • 8.3.2. North America By Segment Sales Analysis
  • 8.3.3. North America By Country Sales Analysis
  • 8.3.4. United State Sales Analysis
  • 8.3.5. Canada Sales Analysis
  • 8.3.6. Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1. Overview, Historic and Forecast Sales Analysis
  • 8.4.2. Europe by Segment Sales Analysis
  • 8.4.3. Europe by Country Sales Analysis
  • 8.4.4. United Kingdom Sales Analysis
  • 8.4.5. France Sales Analysis
  • 8.4.6. Germany Sales Analysis
  • 8.4.7. Italy Sales Analysis
  • 8.4.8. Russia Sales Analysis
  • 8.4.9. Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1. Overview, Historic and Forecast Sales Analysis
  • 8.5.2. Asia Pacific by Segment Sales Analysis
  • 8.5.3. Asia Pacific by Country Sales Analysis
  • 8.5.4. China Sales Analysis
  • 8.5.5. India Sales Analysis
  • 8.5.6. Japan Sales Analysis
  • 8.5.7. South Korea Sales Analysis
  • 8.5.8. Australia Sales Analysis
  • 8.5.9. Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1. Overview, Historic and Forecast Sales Analysis
  • 8.6.2. Latin America by Segment Sales Analysis
  • 8.6.3. Latin America by Country Sales Analysis
  • 8.6.4. Brazil Sales Analysis
  • 8.6.5. Argentina Sales Analysis
  • 8.6.6. Peru Sales Analysis
  • 8.6.7. Chile Sales Analysis
  • 8.6.8. Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1. Overview, Historic and Forecast Sales Analysis
  • 8.7.2. Middle East & Africa by Segment Sales Analysis
  • 8.7.3. Middle East & Africa by Country Sales Analysis
  • 8.7.4. Saudi Arabia Sales Analysis
  • 8.7.5. UAE Sales Analysis
  • 8.7.6. Israel Sales Analysis
  • 8.7.7. South Africa Sales Analysis
  • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE SYNTHETIC SMALL MOLECULE API COMPANIES

• 9.1. Synthetic Small Molecule Api Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF SYNTHETIC SMALL MOLECULE API INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Bristol-Myers Squibb Company
  • 10.3.1. Company Overview
  • 10.3.2. Company Revenue
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. Cipla Inc.
  • 10.4.1. Company Overview
  • 10.4.2. Company Revenue
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. Boehringer Ingelheim International GmbH
  • 10.5.1. Company Overview
  • 10.5.2. Company Revenue
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. Merck & Co. Inc.
  • 10.6.1. Company Overview
  • 10.6.2. Company Revenue
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. AbbVie Inc.
  • 10.7.1. Company Overview
  • 10.7.2. Company Revenue
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. Aurobindo Pharma
  • 10.8.1. Company Overview
  • 10.8.2. Company Revenue
  • 10.8.3. Products
  • 10.8.4. Recent Developments
• 10.9. Sun Pharmaceutical Industries Ltd.
  • 10.9.1. Company Overview
  • 10.9.2. Company Revenue
  • 10.9.3. Products
  • 10.9.4. Recent Developments
• 10.10. Teva Pharmaceutical Industries Ltd.
  • 10.10.1. Company Overview
  • 10.10.2. Company Revenue
  • 10.10.3. Products
  • 10.10.4. Recent Developments
• 10.11. Albemarle Corporation
  • 10.11.1. Company Overview
  • 10.11.2. Company Revenue
  • 10.11.3. Products
  • 10.11.4. Recent Developments
• 10.12. Viatris Inc.
  • 10.12.1. Company Overview
  • 10.12.2. Company Revenue
  • 10.12.3. Products
  • 10.12.4. Recent Developments
• 10.13. Dr. Reddy's Laboratories Ltd.
  • 10.13.1. Company Overview
  • 10.13.2. Company Revenue
  • 10.13.3. Products
  • 10.13.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Manufacturer (USD MN)
• In-house Market Sales by Geography (USD MN)
• Outsourced Market Sales by Geography (USD MN)
• Analysis Market by Application (USD MN)
• Cardiology Market Sales by Geography (USD MN)
• Oncology Market Sales by Geography (USD MN)
• CNS And Neurology Market Sales by Geography (USD MN)
• Orthopedic Market Sales by Geography (USD MN)
• Endocrinology Market Sales by Geography (USD MN)
• Pulmonology Market Sales by Geography (USD MN)
• Gastroenterology Market Sales by Geography (USD MN)
• Nephrology Market Sales by Geography (USD MN)
• Ophthalmology Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Synthetic Small Molecule Api Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Synthetic Small Molecule Api Report
• Market Research Process
• Market Research Methodology
• Global Synthetic Small Molecule Api Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Manufacturer
• Market Attractiveness Analysis by Application
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Manufacturer (USD MN)
• In-house Market Sales by Geography (USD MN)
• Outsourced Market Sales by Geography (USD MN)
• Global Market Analysis by Application (USD MN)
• Cardiology Market Sales by Geography (USD MN)
• Oncology Market Sales by Geography (USD MN)
• CNS And Neurology Market Sales by Geography (USD MN)
• Orthopedic Market Sales by Geography (USD MN)
• Endocrinology Market Sales by Geography (USD MN)
• Pulmonology Market Sales by Geography (USD MN)
• Gastroenterology Market Sales by Geography (USD MN)
• Nephrology Market Sales by Geography (USD MN)
• Ophthalmology Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market by Revenue
• North America Market by Revenue
• Europe Market by Revenue
• Asia Pacific Market by Revenue
• Latin America Market by Revenue
• Middle East & Africa Market by Revenue
• Recent Development in Industry
• Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.